HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.

Abstract
Salt-inducible kinases (SIKs) play a crucial role in inflammation process, acting as molecular switches that regulate the transformation of M1/M2 macrophages. HG-9-91-01 is a SIKs inhibitor with potent inhibitory activity against SIKs in the nanomolar range. However, its poor drug-like properties, including a rapid elimination rate, low in vivo exposure and high plasma protein binding rate, have hindered further research and clinical application. To improve the drug-like properties of HG-9-91-01, a series of pyrimidine-5-carboxamide derivatives were designed and synthesized through a molecular hybridization strategy. The most promising compound 8h was obtained with favorable activity and selectivity on SIK1/2, excellent metabolic stability in human liver microsome, enhanced in vivo exposure and suitable plasma protein binding rate. Mechanism research showed that compound 8h significantly up-regulated the expression of anti-inflammatory cytokine IL-10 and reduced the expression of pro-inflammatory cytokine IL-12 in bone marrow-derived macrophages. Furthermore, it significantly elevated expression of cAMP response element-binding protein (CREB) target genes IL-10, c-FOS and Nurr77. Compound 8h also induced the translocation of CREB-regulated transcriptional coactivator 3 (CRTC3) and elevated the expression of LIGHT, SPHK1 and Arginase 1. Additionally, compound 8h demonstrated excellent anti-inflammatory effects in a DSS-induced colitis model. Generally, this research indicated that compound 8h has the potential to be developed as an anti-inflammatory drug candidate.
AuthorsXiaoying Cai, Lun Wang, Yuyao Yi, Dexin Deng, Mingsong Shi, Minghai Tang, Na Li, Haoche Wei, Ruijia Zhang, Kaiyue Su, Haoyu Ye, Lijuan Chen
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 256 Pg. 115469 (Aug 05 2023) ISSN: 1768-3254 [Electronic] France
PMID37178481 (Publication Type: Journal Article)
CopyrightCopyright © 2023. Published by Elsevier Masson SAS.
Chemical References
  • Interleukin-10
  • HG-9-91-01
  • Protein Serine-Threonine Kinases
  • Pyrimidines
  • Cytokines
Topics
  • Humans
  • Interleukin-10
  • Protein Serine-Threonine Kinases
  • Pyrimidines (chemistry)
  • Inflammatory Bowel Diseases (drug therapy)
  • Cytokines (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: